Dubovik, N. S., Guranda, D. F., Ramenskaya, G. V., Tovbin, D. G., Tarasov, D. N., Savchenko, A. Y., & Arnautov, V. S. (2022). Development and Validation of the HPLC Method for Quantification of the Innovative Drug DD217, Factor Xa Inhibitor, in Rat Plasma for a Pharmacokinetic Study. LLC Center of Pharmaceutical Analytics (LLC «CPHA»).
Chicago Style (17th ed.) CitationDubovik, N. S., D. F. Guranda, G. V. Ramenskaya, D. G. Tovbin, D. N. Tarasov, A. Yu Savchenko, and V. S. Arnautov. Development and Validation of the HPLC Method for Quantification of the Innovative Drug DD217, Factor Xa Inhibitor, in Rat Plasma for a Pharmacokinetic Study. LLC Center of Pharmaceutical Analytics (LLC «CPHA»), 2022.
MLA (9th ed.) CitationDubovik, N. S., et al. Development and Validation of the HPLC Method for Quantification of the Innovative Drug DD217, Factor Xa Inhibitor, in Rat Plasma for a Pharmacokinetic Study. LLC Center of Pharmaceutical Analytics (LLC «CPHA»), 2022.